🔎 Trials Near Me

Beranda › Adenokarsinoma Esofagus › Nevada

Uji klinis Adenokarsinoma Esofagus di Nevada

5 studi untuk Adenokarsinoma Esofagus mencari peserta di lokasi di Nevada.

Kota di Nevada

Teks studi resmi (Bahasa Inggris)

Adding Nivolumab to Usual Treatment for People With Advanced Stomach or Esophageal Cancer, PARAMUNE Trial

  • OptumCare Cancer Care at Charleston, Las Vegas
  • OptumCare Cancer Care at Fort Apache, Las Vegas
  • Renown Regional Medical Center, Reno
Menerima pesertaFase 2/3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT06203600

mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma

  • Carson Tahoe Regional Medical Center, Carson City
  • Comprehensive Cancer Centers of Nevada - Henderson, Henderson
  • Comprehensive Cancer Centers of Nevada-Horizon Ridge, Henderson
  • dan 25 lainnya
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT05677490

Symbiotic-GI-16: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Gastroesophageal Cancer

  • Renown Health Medical Oncology, Reno
  • Renown Office of Clinical Research, Reno
  • Renown Regional Medical Center, Reno
Menerima pesertaFase 2/3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT07392892

A Study of CHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid Tumors

  • Comprehensive Cancer Center of Nevada, Las Vegas
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 15 Jul 2026 · NCT06657144

A Study of Sigvotatug Vedotin in Advanced Solid Tumors

  • Comprehensive Cancer Centers of Nevada, Las Vegas
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 6 Jul 2026 · NCT04389632

Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.